3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
108
Lymphoma, Large B-Cell, Diffuse
97
Lymphoma
86
Precursor Cell Lymphoblastic Leukemia-Lymphoma
57
Lymphoma, Non-Hodgkin
37
Lymphoma, Follicular
37
Burkitt Lymphoma
36
Leukemia
31
Multiple Myeloma
29
Lymphoma, Mantle-Cell
26
Hodgkin Disease
25
Lymphoma, T-Cell, Peripheral
20
Lymphoma, Large-Cell, Immunoblastic
15
Lymphoma, Large-Cell, Anaplastic
15
Lymphoma, B-Cell, Marginal Zone
15
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
13
Neoplasm Metastasis
13
Lymphoma, B-Cell
13
Leukemia, Lymphocytic, Chronic, B-Cell
12
Recurrence
11
Neoplasms, Plasma Cell
11
Immunoblastic Lymphadenopathy
11
Lymphoma, T-Cell
8
Dendritic Cell Sarcoma, Interdigitating
8
Blast Crisis
8
Neoplasms
7
Enteropathy-Associated T-Cell Lymphoma
7
Waldenstrom Macroglobulinemia
5
Primary Myelofibrosis
5
Myasthenia Gravis
5
Interventions
Blood Specimen Collection
2
bavituximab
1
Ursodeoxycholic Acid
1
Surveys and Questionnaires
1
Steroids
1
Spermine Synthase
1
Sorafenib
1
Prednisone
1
Phlebotomy
1
Mycophenolic Acid
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Liquid Biopsy
1
Clinical Protocols
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hepatitis
×
Prednisone
×
Clear all
NCT04810156
2022-12-14
I-HEP
Herlev Hospital
Phase 2
Unknown
60 enrolled